- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Syros Pharmaceuticals Stock (NASDAQ:SYRS), Quotes and News Summary
Syros Pharmaceuticals Stock (NASDAQ: SYRS)
| Day Range5.31 - 5.71 | 52 Wk Range5.25 - 38.5 | Open / Close5.67 / 5.34 | Float / Outstanding18.8M / 20.3M |
| Vol / Avg.179.6K / 213.8K | Mkt Cap108.4M | P/E- | 50d Avg. Price8.19 |
| Div / Yield- | Payout Ratio- | Total Float18.8M | EPS-5.4 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-04 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -3.500 | -5.400 | -1.9000 | ||||
| REV | 4.570M | 6.276M | 1.706M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Syros Pharmaceuticals Questions & Answers
You can purchase shares of Syros Pharmaceuticals (NASDAQ: SYRS) through any online brokerage.
Other companies in Syros Pharmaceuticals’s space includes: Alzamend Neuro (NASDAQ:ALZN), Inozyme Pharma (NASDAQ:INZY), PepGen (NASDAQ:PEPG), Atossa Therapeutics (NASDAQ:ATOS) and Portage Biotech (NASDAQ:PRTG).
The latest price target for Syros Pharmaceuticals (NASDAQ: SYRS) was reported by Oppenheimer on Wednesday, August 10, 2022. The analyst firm set a price target for 3.00 expecting SYRS to fall to within 12 months (a possible -43.82% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $5.34 last updated Today at September 27, 2022, 8:00 PM UTC.
There are no upcoming dividends for Syros Pharmaceuticals.
Syros Pharmaceuticals’s Q3 earnings are confirmed for Friday, November 4, 2022.
There is no upcoming split for Syros Pharmaceuticals.
Syros Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.